News & Updates

A large multisite evaluation found that produce prescriptions were associated with statistically significant and clinically meaningful health improvements, including clinical biomarkers of cardiometabolic health, in adults and children.

The selective small molecule inhibitor of lipoprotein(a) (Lp[a]) formation muvalaplin helps reduce Lp(a) levels by up to 65 percent without safety and tolerability signals, as shown in the results of a phase I trial.

Lowering bad cholesterol can help prevent major vascular events in older individuals aged ≥70 years similarly as those aged <70 years, suggests a recent study.

Among high-risk individuals, women are less likely than men to achieve the guideline-recommended low-density lipoprotein cholesterol (LDL-C) target, as shown in a study.

Perioperative myocardial injury (PMI), as shown by perioperative high-sensitivity cardiac troponin T (hs-cTnT) release, appears predictive of expected 30-day mortality, but not 5-year mortality, in patients undergoing cardiac surgery, reveals a recent study.